Lilleng R, Paksoy N, Vural G, Langmark F, Hagmar B
Department of Pathology, Norwegian Radium Hospital, Montebello, Oslo.
Acta Cytol. 1995 Sep-Oct;39(5):877-81.
To investigate the diagnostic accuracy of fine needle aspiration cytology (FNAC) from breast lesions in males and to determine the frequency of benign versus malignant histopathologic diagnoses in surgical biopsies from male breast lesions.
FNAC specimens from breast lesions taken from 241 males over 8.5 years were divided into four subgroups according to the original cytologic diagnoses. Diagnostic accuracy was verified with the Norwegian Cancer Registry. Ten years' worth of material from 809 surgical biopsies from male breast lesions was subgrouped according to the original histopathologic diagnoses.
Of the 809 surgical biopsies, 779 (96.3%) were benign lesions. Of the 241 fine needle aspirates, 27 (11.2%) were unsatisfactory for cytologic diagnosis. Of the remaining 214 cases, 200 benign cytologic diagnoses were confirmed at follow-up. Thus, there were no false negative cytologic diagnoses; eight malignant diagnoses were confirmed by later histopathologic examination of the surgical biopsy.
To reduce the high rate of surgical biopsies of benign male breast masses, we conclude that FNAC should be performed as a standard procedure in the clinical evaluation of male breast lesions.
研究男性乳腺病变细针穿刺细胞学检查(FNAC)的诊断准确性,并确定男性乳腺病变手术活检中良性与恶性组织病理学诊断的频率。
对8.5年期间取自241名男性的乳腺病变FNAC标本,根据原始细胞学诊断分为四个亚组。诊断准确性通过挪威癌症登记处进行验证。对取自男性乳腺病变的809例手术活检的十年材料,根据原始组织病理学诊断进行亚组分析。
在809例手术活检中,779例(96.3%)为良性病变。在241例细针抽吸物中,27例(11.2%)细胞学诊断不满意。在其余214例病例中,随访证实200例细胞学诊断为良性。因此,没有假阴性细胞学诊断;8例恶性诊断通过手术活检的后续组织病理学检查得到证实。
为降低男性乳腺良性肿块的高手术活检率,我们得出结论,FNAC应作为男性乳腺病变临床评估的标准程序进行。